UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Hydroxychloroquine in Hand Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Arthritis care & research (2010), 2018-09, Vol.70 (9), p.1320-1325

2018

Volltextzugriff (PDF)

Single-Cell RNA Sequencing Reveals Heterogeneity and Functional Diversity of Lymphatic Endothelial Cells

International journal of molecular sciences, 2021-11, Vol.22 (21), p.11976

2021

Volltextzugriff (PDF)

Characterizing memory T helper cells in patients with psoriasis, subclinical, or early psoriatic arthritis using a machine learning algorithm

Arthritis research & therapy, 2022-01, Vol.24 (1), p.28-28, Article 28

2022

Volltextzugriff (PDF)

Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2019-10, Vol.71 (10), p.1711-1722

2019

Volltextzugriff (PDF)

Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients

International journal of molecular sciences, 2020-12, Vol.21 (24), p.9544

2020

Volltextzugriff (PDF)

Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial

Arthritis research & therapy, 2019-09, Vol.21 (1), p.208-208, Article 208

2019

Volltextzugriff (PDF)

Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort

Rheumatic & musculoskeletal diseases open, 2024-05, Vol.10 (2), p.e004080

2024

Volltextzugriff (PDF)

Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial

Rheumatic & musculoskeletal diseases open, 2023-06, Vol.9 (2), p.e002905

2023

Volltextzugriff (PDF)

Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis

Arthritis research & therapy, 2019-01, Vol.21 (1), p.25-25, Article 25

2019

Volltextzugriff (PDF)

Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial

Rheumatic & musculoskeletal diseases open, 2024-04, Vol.10 (2), p.e003659

2024

Volltextzugriff (PDF)

Window of opportunity in psoriatic arthritis: the earlier the better?

Rheumatic & musculoskeletal diseases open, 2024-02, Vol.10 (1), p.e004062

2024

Volltextzugriff (PDF)

Construct validity and responsiveness of feasible composite disease activity measures for use in daily clinical practice in patients with psoriatic arthritis

Rheumatic & musculoskeletal diseases open, 2023-10, Vol.9 (4), p.e002972

2023

Volltextzugriff (PDF)

Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis

Rheumatic & musculoskeletal diseases open, 2020-07, Vol.6 (2), p.e001175

2020

Volltextzugriff (PDF)

Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial

Rheumatology (Oxford, England), 2019-08, Vol.58 (8), p.1344-1352

2019

Volltextzugriff (PDF)

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

Annals of the rheumatic diseases, 2022-07, Vol.81 (7), p.925-936

2022

Volltextzugriff (PDF)

Capturing Patient Value in an Economic Evaluation

Arthritis care & research (2010), 2024-02, Vol.76 (2), p.191-199

2024

Volltextzugriff (PDF)

The Development and Validation of a Novel Training Infographic for the Physician Global Visual Analog Scale in Psoriatic Arthritis

Journal of rheumatology, 2024-08, p.jrheum.2024-0152

2024

Volltextzugriff (PDF)

Addressing Health Literacy Needs in Rheumatology: Which Patient Health Literacy Profiles Need the Attention of Health Professionals?

Arthritis care & research (2010), 2021-01, Vol.73 (1), p.100-109

2021

Volltextzugriff (PDF)

Reduced Occurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis Treated with Golimumab - The GO-EASY Study

Journal of rheumatology, 2019-02, Vol.46 (2), p.153-159

2019

Volltextzugriff (PDF)

Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial

Annals of the rheumatic diseases, 2023-10, Vol.82 (10), p.1307-1314

2023

Volltextzugriff (PDF)

Rituximab dose-dependent infection risk in rheumatoid arthritis is not mediated through circulating immunoglobulins, neutrophils or B cells

Rheumatology (Oxford, England), 2022-12, Vol.62 (1), p.330-334

2022

Volltextzugriff (PDF)

Taking advances from bench to bedside during the last decade

Best practice & research. Clinical rheumatology, 2012-04, Vol.26 (2), p.225-236

2012

Volltextzugriff (PDF)

Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome

Arthritis research & therapy, 2009-01, Vol.11 (6), p.R189-R189

2009

Volltextzugriff (PDF)

Reengineered Salivary Glands Are Stable Endogenous Bioreactors for Systemic Gene Therapeutics

Proceedings of the National Academy of Sciences - PNAS, 2004-03, Vol.101 (9), p.3053-3058

2004

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(123)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Efficacy of Hydroxychloroquine in Hand Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Single-Cell RNA Sequencing Reveals Heterogeneity and Functional Diversity of Lymphatic Endothelial Cells

Characterizing memory T helper cells in patients with psoriasis, subclinical, or early psoriatic arthritis using a machine learning algorithm

Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis

Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients

Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial

Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort

Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial

Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis

Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial

Window of opportunity in psoriatic arthritis: the earlier the better?

Construct validity and responsiveness of feasible composite disease activity measures for use in daily clinical practice in patients with psoriatic arthritis

Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis

Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial

Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

Capturing Patient Value in an Economic Evaluation

The Development and Validation of a Novel Training Infographic for the Physician Global Visual Analog Scale in Psoriatic Arthritis

Addressing Health Literacy Needs in Rheumatology: Which Patient Health Literacy Profiles Need the Attention of Health Professionals?

Reduced Occurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis Treated with Golimumab - The GO-EASY Study

Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial

Rituximab dose-dependent infection risk in rheumatoid arthritis is not mediated through circulating immunoglobulins, neutrophils or B cells

Taking advances from bench to bedside during the last decade

Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome

Reengineered Salivary Glands Are Stable Endogenous Bioreactors for Systemic Gene Therapeutics

Suchergebnisse filtern